Compare Freeport-McMoRan Inc (FCX) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freeport-McMoRan Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Freeport-McMoRan Inc trades at $68.72 (market cap $104.00B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Freeport-McMoRan Inc is far larger — about 20.1× Oruka Therapeutics Inc. Common Stock's market cap, and Freeport-McMoRan Inc pays a 0.83% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Freeport-McMoRan Inc for 70 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| FCX | ORKA | |
|---|---|---|
Market Cap | $104.00B | $5.18B |
Volume | 7,316,762 | 490,798 |
Sector | Basic Materials | Health |
52-Week High | $79.91 | $113.08 |
52-Week Low | $38.65 | $26.19 |
Typical Hold Time | 70 Days | 0 Days |
Enterprise Value | $110.28B | $4.31B |
Dividend Yield | 0.83% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCX trades at $72.42, down 1.19% today, with a bullish technical signal from moving averages and a consensus analyst price target of $73.50. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue reached $25.92B in 2025, and net income margin improved to 11.38%. Strong cash flow from operations of $5.61B supports dividend payments and growth projects amid rising copper demand driven by AI and data centers.
FCX presents a positive outlook with robust fundamentals and favorable copper market dynamics, but faces risks from cost pressures and regulatory scrutiny. Earnings growth and expansion initiatives are key catalysts, while investor sentiment remains bullish based on analyst ratings.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
